MESO Nasdaq update, page-5435

Yes Reg.

I read that the other day & liked that the poster, despite his/her cycnicism, was forced to credit MSB with good prospects for the resub.

I have some very old material where Danilkovich provides his view on Osiris' potency assays, & TNFR1 in particular. All v interesting stuff. You have to wonder where the line between publicly available and not publicly available really lies. But I feel pretty confident there will be not publicly available info & that all publicly available info won't be found in a patent application.

Cheers
But still your shout